Agado Live
AI platform empowering neurological PTs to treat more patients with the same staff
Company Overview
Snapshot
Founded in January 2021 by Tzach Goren, Gili Yaron, Vittaly Tavor, and Gil Shamai, Agado Live operates with 11–50 employees. The company has secured funding across two rounds and received a grant from the BIRD Foundation in July 2023.
Business overview
Agado Live develops an AI platform designed to enhance the efficiency of neurological physical therapists. Leveraging artificial intelligence and computer vision, their solution enables therapists to conduct real-time sessions with multiple patients simultaneously, aiming to expand treatment capacity without compromising service quality. The company operates within the Health Tech & Life Sciences sector, serving healthcare providers with B2B and B2B2C business models, and offers products like Agado Health and Agado Evaluation.
Strategic signal
Agado Live's participation in the Google for Startups Accelerator program, graduating in April 2023, signals strategic validation and potential for accelerated growth. This involvement suggests the company is actively refining its business model and technology with support from a major tech entity, positioning it for broader market penetration and product development in the health tech space.
Log in to access full profile ›Company Intelligence Q&A
- When was Agado Live founded?
- Agado Live was founded in January 2021.
- Who are the founders of Agado Live?
- Agado Live was founded by Tzach Goren, Gili Yaron, Vittaly Tavor, and Gil Shamai.
- What accelerator program did Agado Live graduate from in 2023?
- Agado Live graduated from the Google for Startups Accelerator program in April 2023.
- What is Agado Live's primary business model?
- Agado Live operates with B2B and B2B2C business models, providing its AI platform to healthcare providers.